Alabama Attorney General Steve Marshall, on behalf of 20 states, sent a letter to the American Medical Association (AMA), urging it to drop its cross-sex hormone treatment for minors. While the organization admitted that transgender surgeries for minors lack scientific evidence, the AMA stopped short of condemning puberty blockers.
According to the letter, the states “find it concerning that the AMA continues to support the use of puberty blockers and cross-sex hormones to treat gender dysphoria in minors.” The letter cited conclusions from both the U.S. Department of Health and Human Services and other governments that warned against transgender efforts among youths.
“So if you agree that there is insufficient evidence to support using surgical interventions to treat gender dysphoria in minors — as your recent statement indicates — we do not understand how you can find that there is sufficient evidence to support using hormonal interventions to treat gender dysphoria in minors,” the letter adds. “These interventions have not been shown to be any safer for children than surgeries are, and in fact may be all the more dangerous precisely because they are viewed as not as serious.”
“The American Medical Association has finally admitted what many have warned for years: its recommendations for surgeries on children were not grounded in solid evidence, despite telling doctors and families otherwise,” Marshall said in a statement accompanying the letter. “Yet the same weak science underpins puberty blockers and cross-sex hormones. You cannot dismiss one intervention as unsupported while continuing to push the rest. When children’s lives and futures are at stake, anything less than full scientific honesty is reckless. The AMA must follow the science completely, not selectively.”
While the AMA has opposed sex-change procedures for minors, other medical entities have doubled down on transgender ideology, claiming the Trump administration has targeted them. The American Academy of Pediatrics and the Endocrine Society filed separate lawsuits this month, arguing that the Federal Trade Commission (FTC) unfairly threatened them for their engagement in gender ideology.
